Novartis heart drug gets FDA's 'breakthrough' status

June 21, 2013 5:35 AM

26 0

Novartis heart drug gets FDA's 'breakthrough' status

ZURICH (Reuters) - Swiss pharmaceuticals company Novartis said on Friday U.S. regulators have given breakthrough therapy status to an investigational treatment for patients with acute heart failure, potentially fast tracking its development and approval.

The U.S. Food and Drug Administration (FDA) created the "breakthrough therapy" designation earlier this year for medicines deemed likely to demonstrate "substantial improvement" over existing drugs.

Read more

To category page